Beijing oncology biotech Avistone raises $140M Series B for commercialization in China, expansion into USnews2024-01-04T15:08:22+00:00January 4th, 2024|Endpoints News|
OnCusp secures $100M Series A from Novo, OrbiMed and others to run PhI trialnews2024-01-04T14:25:26+00:00January 4th, 2024|Endpoints News|
AGC Biologics to build new government-funded $350M Japanese facilitynews2024-01-04T14:00:23+00:00January 4th, 2024|Endpoints News|
Lyndra’s long-acting risperidone formulation hits PhIII schizophrenia trial endpointsnews2024-01-04T13:12:04+00:00January 4th, 2024|Endpoints News|
Virta Health, which got its start helping people manage diabetes with diet, launches weight loss programnews2024-01-04T13:00:55+00:00January 4th, 2024|Endpoints News|
ARCH-backed immunology company HI-Bio raises $95Mnews2024-01-04T13:00:46+00:00January 4th, 2024|Endpoints News|
Epigenetics biotech Moonwalk debuts with $57M, backed by CRISPR pioneer Feng Zhangnews2024-01-04T13:00:44+00:00January 4th, 2024|Endpoints News|
As the biotech funding game changed, TCGX altered course — and now they’re back with $1B for round twonews2024-01-04T13:00:12+00:00January 4th, 2024|Endpoints News|
Bayer and AskBio reveal early safety data for Parkinson’s gene therapy, plot PhII studynews2024-01-04T12:12:03+00:00January 4th, 2024|Endpoints News|
Roche pens third pact of the week in $66M upfront to MOMA Therapeuticsnews2024-01-04T12:00:56+00:00January 4th, 2024|Endpoints News|
